[Treatment of bronchial obstruction with a combination of a selective beta adrenergic (fenoterol) and a cholinolytic agent (ipratropium)].
D001249:Asthma / Q000188:drug therapy*; D001286:Atropine Derivatives / Q000008:administration & dosage*; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage*; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage*; D008297:Male; D010276:Parasympatholytics / Q000008:administration & dosage*
D001286:Atropine Derivatives; D004983:Ethanolamines; D010276:Parasympatholytics; D005280:Fenoterol; D009241:Ipratropium
Lécba průskové obstrukce kombinací selektivního beta adrenergika (fenoterol) s cholinolytikem (ipratropium).